期刊文献+

RP-HPLC法测定Beagle犬血浆中的烟酸浓度及药动学研究

Determination of niacin in dog plasma by RP-HPLC and its pharmacokinetics study
暂未订购
导出
摘要 目的建立反相高效液相色谱法测定犬血浆中烟酸的浓度,并应用到烟葺盘缓释片在Beagle犬体内的药动学研究。方法采用高氯酸沉淀蛋白处理血浆样本;色谱条件:MegresC18柱(4.6mm×250mm,5μm),流动相:甲醇-10mmol·L-1磷酸二氢钾缓冲溶液(3:97,v/V),柱温;12℃。流速:0.8ml·min^-1,检测波长:263nm;比格犬灌胃蛤药500mg烟酸缓释片。结果线性范围为0.200-35.0ug·mL^-1(r≥0.9996),检测限为50ng·mL^-1,方法回收率为98.4%;烟酸缓释片表现出明显的缓释效果。结论方法操作简单、专属灵敏、重现性好,适用于Beagle犬体内烟馥的药动学研究。 OBJECTIVE To establish a RP-HPLC method for the determination of niacin in dog plasma and the applied to a pharmacokinetics study of sustained-release(SR) niacin tablet in beagle dogs. METHEDS Sample pretreatment procedures involved protein precipitation by 14 % perchloric acid. Separation was performed on a Megres C18 column (4.6mm× 250mm, 5μm) and methanol-10mmol. L-1 KH2PO4 buffer (pH 2.6) with the ratio of 3:97(V/V) as the mobile phase at a flow rate of 0.8mL.min-1. The column temperature was 12℃ and the detection wavelength of263nm. Beagle dog was given 500mg SR niacin tablet by oral administration. RESULTS The linear range was 0.200 N 35.0μg.mL^-1 with r≥0.9996. The limit of determination was 50ng.mL-1. The mean recovery of niacin was 98.4 %. SR niacin tablet showed obvious sustained release effect. CONCLUTION The present RP-HPLC method was specific, simple, sensitive and applicable for the pharmaceutical study of niacin in beagle dogs.
出处 《海峡药学》 2013年第1期271-273,共3页 Strait Pharmaceutical Journal
关键词 烟酸缓释片 犬血浆 药代动力学 反相高效液相色谱 sustained-release niacin tablet dog plasma pharmacokinetics RP-HPLC
  • 相关文献

参考文献9

二级参考文献18

  • 1陈钧,陆伟,蒋新国.高效液相色谱法测定人血浆中的烟酸[J].药物分析杂志,2004,24(4):349-351. 被引量:4
  • 2INSULL W J, MCGOVERN M E, SCHROTr H, et al. Efficacy of extended-release niacin with Lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surfacegraph analysis [ J ]. Arch Intern Med,2004,164:1121 - 1125.
  • 3SHIBATA K. Simultaneous measurement of nicotinic acid and its major metabolite, nicotinuric acid in blood and urine by a reversed-phase high performance liquid chromatography[ J]. Agfic Biol Chem, 1988,52 ( 11 ) : 2973 - 2976.
  • 4HENGEN N, SEIBERTH V, HENGEN M. High-performance liquid chromatographic determination of free nicotinic acid and metabolite, nicotinuric acid, in plasma and urine. [ J ]. Clin Chem, 1978,24 (10) : 1740 - 1743.
  • 5STEIN J, HAHN A, REHNER G. High-pcrformance liquid chromatographic determination of nicotinic acid and nicotinamide in biological samples applying postcolumn derivatization resulting in bathmochrome absorption shifts. [ J]. Chromatogr B, 1995,665:71 -78.
  • 6NEUVONEN PJ, ROIVAS L, LAINE K, et al. The bio- availability of sustained release nicotinic acid formulations. [ J ]. J Clin Pharmacol, 1991,32:473 - 476.
  • 7CHENXiu(陈修).Cardiovascular Pharmacology(心血管药理学)[M].Beijing(北京):People’s Medical Publishing House(,1997.514.
  • 8Masahiro Iwaki, Etsuko Murakami, Kazuaki Kakehi. Chromatographic and capillary electrophoretic methods for the analysis of nicotinic acid and its metabolites. J Chromatogr B ,2000,747:229.
  • 9Neuvonen PJ, Roivas L, Laine K, Sundholm O. The bioavailability of sustained release nicotinic acid formulations[J]. Br J Clin Pharmacol, 1991; 32:473 - 6
  • 10Iwaki M, Ogiso T, Hayashi H, Tanino T, Benet LZ. Acute dose-dependent disposition studies of nicotinic acid in rats[J].Drug Metab Dispos,1996; 24: 773- 9

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部